Day 1

Day 1 Day 2 Day 3 Speaker Faculty Register

DAY ONE – Sunday, 30 March 2014

General O&G track
08:30 Opening remarks by chair:
Dr Saad Aswad, Consultant Gynaecological Oncologist, Obs & Gynae Department, Tawam Hospital, Al Ain, UAE
08:35 When should we offer prenatal karyotyping?
Dr Marcin Wiechec, Consultant in Foetal Diagnostics and Ultrasound, Obstetrics and Perinatology Clinic, University Hospital, Krakow, Poland
09:05

Dsyfunctional uterine bleeding
Professor David Barlow,
Director, Women’s Services, Hamad Medical Corporation, Doha, Qatar

09:30 What the gynaecologist needs to know about ovarian borderline tumours
Dr Nadeem Abu-Rusum, Vice Chair, Technology Development, Department of Surgery, Director, Minimally Invasive Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
10:00 Modern staging of endometrial cancer – the role of sentinel nodes
Dr Nadeem Abu-Rusum, Vice Chair, Technology Development, Department of Surgery, Director, Minimally Invasive Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
10:30 COFFEE BREAK
  TRACK A: Gynaeologic oncology Track B: Foetal medicine
11:00

Breast cancer and pregnancy
Dr Hikmat N. Abdel-Razeq, Chief Medical Officer, Deputy Director General, King Hussein Cancer Center, Amman, Jordan

Congenital foetal infection
Dr Maha Al Nemer, Member, Saudi Maternal Fetal Medicine Group, Riyadh, Saudi Arabia
11:20 Fertility sparing surgery for stage I cervical cancer: A new standard of care
Dr Nadeem Abu-Rusum,
Vice Chair, Technology Development, Department of Surgery, Director, Minimally Invasive Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
Intrapartum ultrasound: Is it helpful?
Dr Samir Abdulla,
Division of Maternal-Foetal Medicine, King Faisal Specialist Hospital, Chairman, Saudi Maternal Fetal Medicine Group, Riyadh, Saudi Arabia
11:45 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the management of advanced and recurrent ovarian cancer; the local experience
Dr Ismail-Al Badawi,
Consultant, Gynaecologic Oncologist, Department of Obstetrics and Gynaecology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Role of MRI in prenatal diagnosis
Dr Maher Al Nemer,
Member, Saudi Maternal Fetal Medicine Group, Riyadh, Saudi Arabia
12:05

Cervical cancer prevention updates: HPV testing vs. conventional cytology
Dr Muhieddine Seoud, FACOG,
Vice Chairman, Professor of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, American University of Beirut Medical Center, Beirut, Lebanon

 
12:30 LUNCH BREAK LUNCH BREAK
14:00 Fertility-sparing treatment of endometrial cancer: Who are the candidates?
Dr Nadeem Abu-Rusum,
Vice Chair, Technology Development, Department of Surgery, Director, Minimally Invasive Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
Assessment of foetal cardiac function
Dr Hamdan Mohamed, Paediatric Cardiology, KidsHeart: American Fetal & Children's Heart Center, Dubai, UAE
14:20 Prognostic pathological parameters in endometrial cancer: What matters in the histology report?
Dr Asif Quadri,
Consultant Obs & Gynae, Tawam Hospital, Al Ain, UAE
3D examination of the fetal brain
Dr Marcin Wiechec,
Consultant in Foetal Diagnostics and Ultrasound, Obstetrics and Perinatology Clinic, University Hospital, Krakow, Poland
14:40 The role of PET scan in management of female genital cancer
Dr Muhammad Ali Chaudhry, M
edical Director, Tawam Molecular Imaging Center, Clinical Assistant Professor of Radiology,Johns Hopkins University School of Medicine, Al Ain, UAE
Cervical assessment during pregnancy
Dr Maha Al Nemer,
Member, Saudi Maternal Fetal Medicine Group, Riyadh, Saudi Arabia
15:00 Incidence of human papilloma virus in Saudi women
Dr Ismail Al-Badawi,
Consultant, Gynaecologic Oncologist, Department of Obstetrics and Gynaecology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
What is that? Things we see during anomaly scan
Dr Hisham Mirghani,
FRCOG, Consultant, Obstetrics/Foetal Medical, Faculty of Medicine & Health Sciences, UAE University, Al Ain, UAE
15:20 The epidemiological date of gynae cancer in the UAE
Dr Thikra Hassan,
Consultant Obstetric and Gynaecology/Gynae-Oncology, Female Reproductive System Tumors Specialist, Tawam Hospital, Al Ain, UAE
Renal pelvis dilation: Should we worry?
Dr Marcin Wiechec,
Consultant in Foetal Diagnostics and Ultrasound, Obstetrics and Perinatology Clinic, University Hospital, Krakow, Poland
15:40 Outcome of low risk (GTN) treated with methotrexate
Dr Abdulaziz Alobaid,
Assistant Professor, Gynaecologic Oncology, King Saud University, Riyadh, Saudi Arabia
Revisiting prenatal Doppler
Dr Samir Abdulla, Division of Maternal-Foetal Medicine, King Faisal Specialist Hospital, Chairman, Saudi Maternal Fetal Medicine Group, Riyadh, Saudi Arabia
16:00 COFFEE BREAK COFFEE BREAK
16:30

Gyne cancer tumour board
Dr Hassan Jaafar, Consultant Medical Oncology, Tawam Hospital, Al Ain, UAE

Sorting the dilemma of cervical pregnancy
Dr Muzibunnisa Begam,
Dept of Obs & Gynae, Foetal Medicine Unit, Tawam Hospital, Al Ain, UAE
17:00   How much do patients in the UAE know about folic acid?
Dr Mariam Al Ketbi, Consultant Obs & Gynae, CMHS, UAE University, Al Ain, UAE
17:30 CLOSE OF DAY ONE CLOSE OF DAY ONE

Download Post Show Report

Obs-Gyne Exhibition and Congress Post Show Report image

Join us

Grantor Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:

Platinum Sponsor

Gold Sponsors

ROCHE

Media Partners

Al tibbi CRC Press Eye of Riyadh Good Health
Hospitals by Arab Hospital Magazine

Supported by

Organised By

Informa Exhibitions